methotrexate has been researched along with Osteoporosis, Postmenopausal in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamada, T; Hara, T; Jingushi, S; Kamo, Y; Maekawa, M; Miyanishi, K; Moro-oka, TA; Torisu, T; Tsurusaki, S | 1 |
Lewiecki, EM | 1 |
Bazakas, A; Ladizinski, B; Olsen, EA; Selim, MA | 1 |
Espirito, JL; Games, DM; McCune, JS | 1 |
Briot, K | 1 |
Náfrádi, L; Toldy, E; Varga, L | 1 |
Gündüz, OH; Ozoran, K; Uçan, H; Yilmaz, L; Yücel, M | 1 |
Beresford, JN; Bhalla, AK; Compston, JE; Kounali, D; Minaur, NJ; Vedi, S | 1 |
2 review(s) available for methotrexate and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Denosumab for joints and bones.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Denosumab; Drug Therapy, Combination; Female; Humans; Joints; Methotrexate; Middle Aged; Osteoclasts; Osteoporosis, Postmenopausal; RANK Ligand | 2009 |
[Non-corticosteroid drug-induced metabolic bone disease].
Topics: Aged; Animals; Anticoagulants; Anticonvulsants; Antipsychotic Agents; Aromatase Inhibitors; Bone Density; Child; Cyclosporins; Densitometry; Disease Progression; Diuretics; Female; Follow-Up Studies; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Iatrogenic Disease; Immunosuppressive Agents; Lithium Compounds; Male; Menopause; Methotrexate; Middle Aged; Osteomalacia; Osteoporosis; Osteoporosis, Postmenopausal; Placebos; Prospective Studies; Protease Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tacrolimus; Thyroid Hormones; Time Factors | 2006 |
3 trial(s) available for methotrexate and Osteoporosis, Postmenopausal
Article | Year |
---|---|
[Measure of bone loss in rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Adult; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Densitometry; Female; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal | 1999 |
Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids.
Topics: Absorptiometry, Photon; Aged; Alendronate; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Calcium; Clinical Chemistry Tests; Drug Therapy, Combination; Female; Hematologic Tests; Humans; Methotrexate; Middle Aged; Osteoporosis, Postmenopausal; Prednisolone; Treatment Outcome | 2001 |
Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Middle Aged; Osteoporosis, Postmenopausal; Outpatient Clinics, Hospital; Prospective Studies; Sulfasalazine | 2002 |
3 other study(ies) available for methotrexate and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Co-occurrence of subchondral insufficiency fracture of the femoral head and contralateral femoral neck fracture in a rheumatic patient receiving steroid treatment.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Therapy, Combination; Female; Femoral Neck Fractures; Femur Head; Fractures, Stress; Hip Fractures; Hip Joint; Humans; Magnetic Resonance Imaging; Methotrexate; Osteonecrosis; Osteoporosis, Postmenopausal; Prednisolone | 2008 |
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Anti-Bacterial Agents; Azasteroids; Cicatrix; Dutasteride; Enzyme Inhibitors; Eyebrows; Female; Fibrosis; Forehead; Hospitals, University; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus; Methotrexate; Middle Aged; Minocycline; Osteoporosis, Postmenopausal; Retrospective Studies; Scalp; Tacrolimus; Treatment Outcome | 2013 |
Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Breast Neoplasms; Calcium; Contraceptives, Oral; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Utilization Review; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Follow-Up Studies; Goserelin; Humans; Medical Records; Menstruation Disturbances; Methotrexate; Osteoporosis, Postmenopausal; Premenopause; Primary Ovarian Insufficiency; Process Assessment, Health Care; Retrospective Studies; Survivors; Tamoxifen; Time Factors | 2005 |